Its operating profit grew 154.4% in the first nine months, to RON29 million. Operating expenses grew 23%, to RON434 million, accounting for 94.6% of total expenses.
MedLife had a consolidated turnover of RON459.18 million in January-September, up 27% on the year, driven by growth on all segments, particularly dentistry, clinics and laboratories and acquisitions the group finalized in 2016 and 2017.
Medlife’s clinics had a turnover of RON123 million in January-September, up 35% on the year, its hospitals had sales of RON88 million, up 13%, Labs had sales of RON85 million, up 24%, and its pharmacies had sales of RON21 million, up 25%. The operator’s dentistry business had sales of RON28 million, up 191%, and the corporate services segment had sales of RON105 million, up 13%.
The company’s current debts (excluding interest-bearing debts) grew 0.13%, to RON119.79 million end-September 2017 from RON117 million end-September 2016.
Interest-bearing debts grew by RON 65.28 million, to RON305 million, after it bought 80% of Almina Trading SA and the Anima medical network.
MedLife is in final talks to buy the Polisano clinic network and hospital, which had a turnover of EUR17 million in 2016.